UCDS Schools
Education · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5062 9th Ave NE, Seattle, Washington, 98...Phone Number
(206) 547-8237Website
www.ucds.orgRevenue
$11.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
2
1
About UCDS Schools
UCDS Schools is an independent educational institution offering programs from preschool through 5th grade, including an Infant-Toddler Education Program. The school focuses on developing reflective and collaborative thinkers, encouraging students to embrace their unique strengths and engage in lifelong learning. UCDS provides a variety of educational programs tailored to individual learning styles, along with extracurricular activities and support services. Their mission is to cultivate skillful thinkers who can ignite positive change within their communities.Explore more
UCDS Schools Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is UCDS Schools your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if UCDS Schools had a recent Job posting/layoffs
Product Launch: Get notified when UCDS Schools launches new products
Earning: See what the market has to say on UCDS Schools recently announced quarterly report
Check if UCDS Schools has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once UCDS Schools has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if UCDS Schools is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at UCDS Schools
UCDS Schools, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined UCDS Schools as Masked Content
Find more new buyers
Compare Similar Companies to UCDS Schools
Compare insights from companies similar to UCDS Schools, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
UCDS Schools is experiencing very low activity levels compared to other companies in the Education sector.
What does this means?
UCDS Schools is drawing exceptional interest within the Education industry, suggesting notable developments or strong market momentum, learn more about UCDS Schools.
UCDS Schools financials insights
Gather financial insights about UCDS Schools, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$1M
UCDS Schools Tech Stack
A closer look at the technologies used by UCDS Schools
See more technologies
Most Recent Scoops
Open Position
Open Position
Funding
UCDS Schools has received an SBA PPP loan for $1-2 million from Heritage Bank.
Funding
UCDS Schools News & Media
Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Genetic Metabolic Dieticians International Conference
NEWTON, Mass. and GENEVA, May 06, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”) and its collaboration partner, Relief Therapeutics Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (“Relief”), today announced the presentation of data evaluating the bioavailability, bioequivalence and taste attributes of ACER-001 (sodium phenylbutyrate) compared to sodium phenylbutyrate (BUPHENYL®) powder during poster sessions at the recent Genetic Metabolic Dieticians International (GMDI) ConAcer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for Inherited Metabolic Disorders Annual Meeting
NEWTON, Mass. and GENEVA, April 12, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”) and its collaboration partner, Relief Therapeutics Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (“Relief”), today announced the presentation of data evaluating the bioavailability, bioequivalence and taste attributes of taste-masked sodium phenylbutyrate (ACER-001) compared to sodium phenylbutyrate (BUPHENYL®) powder during poster sessions at the recent Society for Inherited Metabolic DisordAcer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SIMD and GMDI Conferences
Data to be presented suggests ACER-001 could represent a potential alternative to sodium and glycerol phenylbutyrate for treatment of UCDs Data to be presented suggests ACER-001 could represent a potential alternative to sodium and glycerol phenylbutyrate for treatment of UCDsAcer Therapeutics and Relief Therapeutics Announce Issuance of U.S. Patent 11,154,521 Covering ACER-001 Formulation
Key ACER-001 formulation composition of matter patent strengthens proprietary position in U.S. until 2036 Key ACER-001 formulation composition of matter patent strengthens proprietary position in U.S. until 2036
Read more news
Top Education Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding UCDS Schools
Sign Up For FreeTo access detailed company insights
UCDS Schools is an independent educational institution offering programs from preschool through 5th grade, including an Infant-Toddler Education Program. The school focuses on developing reflective and collaborative thinkers, encouraging students to embrace their unique strengths and engage in lifelong learning. UCDS provides a variety of education... Read More
